×
Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.
YARS2 anticorps (C-Term)
YARS2
Reactivité: Humain
WB, IHC (p)
Hôte: Lapin
Polyclonal
RB14936
unconjugated
N° du produit ABIN1882153
Détail du produit anti-YARS2 anticorps
(cache)
Antigène
Voir toutes YARS2 Anticorps
YARS2
(Tyrosyl-tRNA Synthetase 2, Mitochondrial (YARS2))
Épitope
Tous les épitopes à travers YARS2 Anticorps.
AA 399-427, C-Term
Reactivité
Toutes les réactivités sur YARS2 Anticorps
Humain
Hôte
Toutes les hôtes sur YARS2 Anticorps
Lapin
Clonalité
Toutes les clonalités sur YARS2 Anticorps
Polyclonal
Conjugué
Tous les conjugués à travers YARS2 Anticorps
Cet anticorp YARS2 est non-conjugé
Application
Tous les applications à travers YARS2 Anticorps.
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Homologie
M, Rat
Purification
This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Immunogène
This YARS2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 399-427 amino acids from the C-terminal region of human YARS2.
Clone
RB14936
Isotype
Ig Fraction
Top Product
Discover our top product YARS2 Anticorps primaire
Alternatives
(show)
Information d'application
(cache)
Indications d'application
WB: 1:1000. IHC-P: 1:10~50
Restrictions
For Research Use only
Stockage
(cache)
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Date de péremption
6 months
Références pour anticorps anti-YARS2 (ABIN1882153)
(cache)
Riley, Menezes, Rudinger-Thirion, Duff, de Lonlay, Rotig, Tchan, Davis, Cooper, Christodoulou : "Phenotypic variability and identification of novel YARS2 mutations in YARS2 mitochondrial myopathy, lactic acidosis and sideroblastic anaemia. " dans: Orphanet journal of rare diseases , Vol. 8 , pp. 193 , (2014 ) (PubMed ).
Riley, Cooper, Hickey, Rudinger-Thirion, McKenzie, Compton, Lim, Thorburn, Ryan, Giegé, Bahlo, Christodoulou : "Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia--MLASA syndrome. " dans: American journal of human genetics , Vol. 87 , Issue 1 , pp. 52-9 , (2010 ) (PubMed ).
Bonnefond, Frugier, Touzé, Lorber, Florentz, Giegé, Sauter, Rudinger-Thirion : "Crystal structure of human mitochondrial tyrosyl-tRNA synthetase reveals common and idiosyncratic features. " dans: Structure (London, England : 1993) , Vol. 15 , Issue 11 , pp. 1505-16 , (2007 ) (PubMed ).
Détails sur YARS2
(cache)
Antigène
YARS2
(Tyrosyl-tRNA Synthetase 2, Mitochondrial (YARS2))
Autre désignation
YARS2 (YARS2 Produits )
Synonymes
anticorps 2210023C10Rik, anticorps tyrRS, anticorps CGI-04, anticorps RGD1311696, anticorps MLASA2, anticorps MT-TYRRS, anticorps TYRRS, anticorps tyrosyl-tRNA synthetase 2 (mitochondrial), anticorps tyrosyl-tRNA synthetase 2, anticorps Yars2, anticorps YARS2
Sujet
YARS2 catalyzes the attachment of tyrosine to tRNA(Tyr) in a two-step reaction: tyrosine is first activated by ATP to form Tyr-AMP and then transferred to the acceptor end of tRNA(Tyr).
Poids moléculaire
53199
NCBI Accession
NP_001035526
UniProt
Q9Y2Z4
Vus récemment
(cache)